Hepatitis B News and Research

Latest Hepatitis B News and Research

Vaccine developed at Rockefeller University boosts natural killer T cells in patients with cancer

A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.

4 May 2005

Milk thistle not proven effective in lowering mortality in alcoholic or hepatitis B or C liver disease

While some studies found that liver-related mortality may be significantly reduced in patients treated with milk thistle, these findings were not duplicated in the higher quality clinical trials.

2 May 2005

Small number of genes can predict response to chronic hepatitis C therapy

For the first time, physicians at University Health Network and University of Toronto have identified a small subset of genes that can predict whether a patient with chronic Hepatitis C will be able to respond to current treatments.

2 May 2005

New guidelines for managing chronic kidney disease in patients living with HIV infection

The HIV Medicine Association has released guidelines for managing chronic kidney disease in patients living with HIV infection. They are published in the June 1 issue of Clinical Infectious Diseases.

27 Apr 2005

Abnormal liver tests in a Mediterranean population

recent population-based study in a small town in Southern Italy found that one in eight residents had abnormal liver tests.

26 Apr 2005

Allergic diseases have increased

The rate of allergic diseases (atopy) in adults has steadily increased over the last quarter of the 20th century, but the reason for the increase is still unknown, according to a study published online by the BMJ.

19 Apr 2005

Protection against 12 different communicable diseases available for infants and toddlers

In recognition of National Infant Immunization Week (April 24, 2005 through April 30, 2005), the Nassau County Department of Health urges all parents to ensure that their infants and toddlers are fully protected from the following vaccine preventable diseases: diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, measles, mumps, rubella, hepatitis B, haemophilus influenza (meningitis), varicella (chickenpox), pneumococcal disease and influenza.

12 Apr 2005

Pharmacies to sell syringes without a prescription

Beginning Tuesday, April 12th, pharmacists in San Francisco will be able to sell sterile syringes without a prescription when legislation passed by the Board of Supervisors and signed by Mayor Newsom last month goes into effect.

12 Apr 2005

Framework agreement creates safe blood for China

In an important step to help combat the spread of HIV/AIDS in China, The People's Republic of China's Ministry of Health signed a groundbreaking framework agreement with Washington, D.C.-based Safe Blood International Foundation (Safe Blood International), an organization dedicated to providing a safe blood supply for developing countries to help them stop the spread of HIV/AIDS and other blood-borne diseases at the Ministry of Health in Beijing.

12 Apr 2005

Swedish team find gene with link to major diseases

In an exciting new discovery, which could affect millions of people, scientists from the Karolinska Institute and the Centre for Molecular Medicine (CMM) in Stockholm, Sweden, have identified a gene which links autoimmune diseases with cardiovascular diseases.

12 Apr 2005

First identified gene to link autoimmune diseases with cardiovascular diseases

A common gene variant has been identified as the risk factor behind a number of common diseases by research scientists at Karolinska Institutet and the Centre for Molecular Medicine (CMM), Stockholm, Sweden. Up to a quarter of the population could be affected.

10 Apr 2005

Millions of mothers and children are dying unnecessarily

The millions of seemingly preventable deaths of women and children each year has prompted the United Nations to devote this year’s World Health Day to highlighting their plight.

7 Apr 2005

Staph superbug now far more common in the community

Two teams of experts are saying that a drug-resistant "superbug" previously only found in hospitals is becoming more common in the community and must be aggressively treated. They say that staphylococcus aureus, or staph, infections that are resistant to methicillin and similar drugs can now be put into the category of flesh-eating bacteria and doctors need to be aware of this and exchange antibiotics at the first sign of trouble.

6 Apr 2005

Natural killer cells could lead to new Hepatitis treatments

Researchers have discovered that natural killer T (NKT) cells, the immune system's sentinels, patrol the labyrinthine blood vessels of the liver for invaders or signs of tissue damage and demonstrate a dogged behavior not seen before in other T cells.

4 Apr 2005

Oral sex not sex say teens

Many teenagers in the US do not regard oral sex as sex and one in five say they have experience of it.

4 Apr 2005

Tarvacin shows significant anti-viral activity

Peregrine Pharmaceuticals today announced that there will be two presentations, April 4 and 6, at the American Association of Immunologists (AAI) annual meeting in San Diego, California, indicating the anti-viral potential of its Tarvacin antibody. Dr. Melina Soares of The University of Texas Southwestern Medical Center at Dallas will present pre-clinical data titled "Targeting inside-out phospholipids on viruses in a guinea pig model of Lassa fever."

4 Apr 2005

New trial for treatment of liver disease

The Nonalcoholic Steatohepatitis (NASH) Clinical Research Network is launching its first two clinical trials for the study of NASH, a liver disease that resembles alcoholic liver disease but occurs in patients who drink little or no alcohol.

3 Apr 2005

First UK cases of previously rare disease reported in gay men

A previously rare disease has been reported for the first time in the UK, Lymphograunuloma venereum (LGV) is a genital/anogenital bacterial infection caused by a particularly invasive strain of Chlamydia trachomatis.

3 Apr 2005

CDC experts sent to Angola to help with Marburg epidemic

In an effort to control the Marburg virus outbreak in Angola, Health officials from the Centers for Disease Control and Prevention in Atlanta will assist the World Health Organization by going to Angola to help with outbreak investigation, infection control and laboratory diagnosis of the disease.

30 Mar 2005